Plasma pyrophosphate and vascular calcification in chronic kidney disease
Author(s) -
W. Charles O’Neill,
Mhairi K. Sigrist,
Christopher W. McIntyre
Publication year - 2009
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp362
Subject(s) - medicine , calcification , kidney disease , dialysis , hemodialysis , gastroenterology , end stage renal disease , fibroblast growth factor 23 , vascular disease , endocrinology , parathyroid hormone , calcium
Pyrophosphate (PPi) is a potent inhibitor of vascular calcification and may be deficient in renal failure. We sought to determine whether plasma PPi is affected by dialysis or the mode of dialysis and whether it correlates with vascular calcification.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom